We showed the specific enrichment of hsa05202 transcriptional misregulation in cancer, hsa05210: colorectal cancer, hsa05226: gastric cancer, hsa04151: PI3K-Akt signaling pathway, hsa04080: neuroactive ligand-receptor interaction, and hsa04915: the estrogen signaling pathway in Pathview. This evidence concerns the gene AKT1 and cancer.